Search results

Search for "doxorubicin" in Full Text gives 53 result(s) in Beilstein Journal of Nanotechnology.

Synthesis of boron nitride nanotubes and their applications

  • Saban Kalay,
  • Zehra Yilmaz,
  • Ozlem Sen,
  • Melis Emanet,
  • Emine Kazanc and
  • Mustafa Çulha

Beilstein J. Nanotechnol. 2015, 6, 84–102, doi:10.3762/bjnano.6.9

Graphical Abstract
  • in the presence and absence of a magnetic field and higher cell-associated uptake was found in the presence of a magnetic field. Then, the composites were loaded with doxorubicin (dox) to investigate the viability of LNCaP prostate cancer cells in the magnetic field. It was found that dox-loaded BNNT
  • –NaGdF4:Eu composites had higher toxicity in the presence of a magnetic field due to increased cellular uptake of the composites and thus increased doxorubicin delivery. It can be said that the BNNT–NaGdF4:Eu composites increase the chemotherapy efficiency by the use of an external magnetic field [84
PDF
Album
Review
Published 08 Jan 2015

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer

  • Amanee D Salaam,
  • Patrick Hwang,
  • Roberus McIntosh,
  • Hadiyah N Green,
  • Ho-Wook Jun and
  • Derrick Dean

Beilstein J. Nanotechnol. 2014, 5, 937–945, doi:10.3762/bjnano.5.107

Graphical Abstract
  • efficacy of cancer treatments as stand-alone therapies and in combination with standard chemotherapeutic treatment regimens. The current standard of care for metastatic cancer, doxorubicin (DOX), is presented with challenges, namely toxicity due to a lack of specificity and targeted delivery. Nano-enabled
  • ; doxorubicin; nanodiamond; prostate cancer; targeted drug delivery; Introduction Prostate cancer is the most frequently diagnosed malignancy in men [1]. Typically the disease is slow growing, but in some cases it progresses to an aggressively metastatic state. When prostate cancer becomes metastatic, the
  • current standard of care is chemotherapy, which involves the use of toxic anticancer drugs, like doxorubicin (DOX), to treat cancers by inducing apoptosis. DOX has had high success rates with treating prostate cancer [2]. However, it can cause major side effects such as hair loss, nausea [2][3], and
PDF
Album
Full Research Paper
Published 01 Jul 2014

In vitro toxicity and bioimaging studies of gold nanorods formulations coated with biofunctional thiol-PEG molecules and Pluronic block copolymers

  • Tianxun Gong,
  • Douglas Goh,
  • Malini Olivo and
  • Ken-Tye Yong

Beilstein J. Nanotechnol. 2014, 5, 546–553, doi:10.3762/bjnano.5.64

Graphical Abstract
  • or antigens to be linked to their surface for targeted delivery and imaging [16][17]. More importantly, one is not able to use CTAB-coated AuNRs as a carrier for drug delivery of water insoluble anti-cancer agents (e.g., doxorubicin, paclitaxel) to the cancerous area since their surface is
PDF
Album
Supp Info
Full Research Paper
Published 30 Apr 2014
Other Beilstein-Institut Open Science Activities